Los Angeles Capital Management LLC bought a new stake in shares of Krispy Kreme, Inc. (NASDAQ:DNUT – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 27,559 shares of the company’s stock, valued at approximately $80,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in DNUT. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of Krispy Kreme in the 2nd quarter worth approximately $30,000. R Squared Ltd bought a new stake in Krispy Kreme during the second quarter worth approximately $31,000. IFP Advisors Inc lifted its position in Krispy Kreme by 34.5% in the second quarter. IFP Advisors Inc now owns 12,378 shares of the company’s stock worth $36,000 after purchasing an additional 3,178 shares during the period. Bank of Montreal Can bought a new position in Krispy Kreme during the 2nd quarter valued at $38,000. Finally, 180 Wealth Advisors LLC acquired a new position in shares of Krispy Kreme during the 2nd quarter valued at $47,000. 81.72% of the stock is currently owned by institutional investors.
Krispy Kreme Price Performance
NASDAQ DNUT opened at $3.83 on Wednesday. The company has a current ratio of 0.36, a quick ratio of 0.30 and a debt-to-equity ratio of 1.31. Krispy Kreme, Inc. has a 1 year low of $2.50 and a 1 year high of $11.28. The company has a market cap of $656.08 million, a PE ratio of -1.28 and a beta of 1.33. The stock’s 50-day moving average price is $3.62 and its two-hundred day moving average price is $3.39.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on DNUT shares. JPMorgan Chase & Co. reissued an “underweight” rating on shares of Krispy Kreme in a research note on Wednesday, August 27th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Krispy Kreme in a research report on Wednesday, November 5th. Zacks Research downgraded shares of Krispy Kreme from a “hold” rating to a “strong sell” rating in a report on Monday, August 25th. Capital One Financial reduced their price objective on shares of Krispy Kreme from $6.00 to $4.00 and set an “equal weight” rating for the company in a research report on Thursday, October 2nd. Finally, Singular Research upgraded shares of Krispy Kreme to a “moderate buy” rating in a report on Wednesday, October 22nd. Four analysts have rated the stock with a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $5.51.
Read Our Latest Report on Krispy Kreme
Krispy Kreme Profile
Krispy Kreme, Inc, together with its subsidiaries, produces doughnuts in the United States, the United Kingdom, Ireland, Australia, New Zealand, Mexico, Canada, Japan, and internationally. The company operates through three segments: U.S., International, and Market Development. The company offers doughnut experiences through hot light theater and fresh shops, delivered fresh daily branded cabinets and merchandising units within grocery and convenience stores, quick service restaurants, club memberships, drug stores, and ecommerce, as well as through its branded sweet treat line comprising Krispy Kreme branded sweet treats.
Further Reading
- Five stocks we like better than Krispy Kreme
- What is a penny stock? A comprehensive guide
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- 3 Monster Growth Stocks to Buy Now
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- Top Biotech Stocks: Exploring Innovation Opportunities
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding DNUT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Krispy Kreme, Inc. (NASDAQ:DNUT – Free Report).
Receive News & Ratings for Krispy Kreme Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Krispy Kreme and related companies with MarketBeat.com's FREE daily email newsletter.
